Equities

Q linea AB

Q linea AB

Actions
Health CareMedical Equipment and Services
  • Price (SEK)2.44
  • Today's Change-0.01 / -0.41%
  • Shares traded435.31k
  • 1 Year change-26.51%
  • Beta1.0726
Data delayed at least 15 minutes, as of May 31 2024 17:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Q linea AB is a Sweden-based medical technology company. The Company develops and manufactures in-vitro diagnostic (IVD) solutions for infectious diseases. The Company's core product candidate is ASTar, a fully-automated instrument for Antibiotic Susceptibility Testing (AST). It measures bacteria's antimicrobial susceptibility using the disposables developed by the Company. It is able to provide a susceptibility profile within three to six hours directly from a positive blood culture, which enables early administration of antibiotics specifically targeting the disease-causing pathogen. Its main application is the identification of sepsis in hospital patients and the product is aimed primarily at hospital laboratories.

  • Revenue in SEK (TTM)4.44m
  • Net income in SEK-229.37m
  • Incorporated2007
  • Employees127.00
  • Location
    Q linea ABDag Hammarskjolds Vag 52 AUPPSALA 752 37SwedenSWE
  • Phone+46 184443610
  • Websitehttps://www.qlinea.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
China High Precision Automatin Group Ltd208.59m-36.80m224.90m446.00--0.0901--1.08-0.0263-0.02630.14931.790.07934.981.96---1.40-2.32-1.45-2.4124.318.24-17.64-34.3922.04--0.0005--2.315.7936.76---16.16--
Ncte AG-1.14tn-1.14tn226.10m26.00------------------------------------------------------------
Odawara Auto-Machine Mfg Co Ltd304.70m23.15m230.28m185.009.870.86547.450.7558109.90109.901,447.791,253.720.66561.553.7824,611,800.005.061.818.212.5937.7529.007.602.491.10135.700.347942.70-16.153.30549.98---16.0411.63
Winland Holdings Corp33.30m536.91k255.29m9.00384.018.56384.927.670.01320.01320.82740.59011.073.467.17--1.723.152.153.9630.0732.821.612.282.65--0.0352---11.90-2.89-1,063.64---12.94--
Bewhere Holdings Inc99.49m5.98m262.80m--44.424.6529.622.640.00880.00880.14560.08391.3510.575.42--8.13-0.42410.05-0.525138.1929.686.01-0.33243.66--0.0927--20.2527.28-73.40---61.46--
Biohit Oyj149.26m21.13m267.34m42.0016.023.0810.571.790.11980.11980.85270.62371.095.103.80--15.47-5.8820.55-7.1964.7363.5214.16-7.473.58--0.0693--19.405.66207.99--75.26--
Accelerate Diagnostics Inc128.10m-621.68m276.24m134.00------2.16-4.54-4.540.82-1.180.29782.055.2490,805.97-144.52-75.24---94.4628.3235.08-485.31-638.551.29--2.93---5.4316.291.40--0.7307--
Manas Enerji Yonetimi Sanayi ve Ticrt AS89.94m12.87m279.76m--21.601.6815.183.110.47910.47913.366.170.36520.74643.50--5.224.837.757.3954.8545.8214.3111.060.53062.220.2869--88.4741.7269.1084.8756.21--
Q linea AB4.44m-229.37m285.89m127.00--1.51--64.39-5.35-5.350.06751.620.01920.0776148.0034,960.63-99.32-59.66-120.55-66.1422.41-378.58-5,165.90-4,046.974.10--0.0978---65.2833.0214.64--41.94--
PNE Industries Ltd450.54m9.95m300.74m1.19k30.220.57413.380.66750.01520.01520.68910.80140.70552.113.43--1.563.701.824.5219.5020.922.214.724.6333.670.0227107.73-27.40-7.69-79.11-32.22-2.26-9.71
Serstech AB64.75m1.91m310.05m24.0074.006.5224.224.790.02030.02030.32540.231.034.6112.303,083,381.003.03-21.124.00-26.6275.6380.732.95-44.611.8259.210.0246--267.6542.82102.42--19.34--
Multisensor AI Holdings Inc70.80m-245.11m312.74m35.00--20.51--4.42-1.95-1.950.56230.1053------192,142.90--------26.77---346.22--0.3282--0.629---25.29---67.55------
Atrem SA415.41m25.30m324.41m133.0012.822.9010.710.7811.031.0316.844.541.59500.1817.241,168,564.009.712.1921.875.0217.1311.626.091.741.26--0.3625--28.591.40135.34---15.15--
Precision System Science Co., Ltd.268.46m-89.36m342.52m199.00--1.12--1.28-48.33-48.33145.18165.790.46051.565.2220,158,780.00-15.33-1.10-19.53-1.4720.9131.92-33.29-1.481.66-36.870.2387---29.007.71-3,020.99--6.22--
Owlet Inc610.85m-249.37m351.48m76.00------0.5754-2.87-2.876.71-2.421.062.944.30763,473.70-32.36---181.41--43.05---30.61--0.8182-43.37-----21.95--52.74------
Autoscope Technologies Corp-1.05tn-1.05tn353.30m36.00--2.15----------2.85----------14.49--15.89--78.50--19.7017.64--0.0932---6.32-3.10-47.58-25.45-14.49--
Data as of May 31 2024. Currency figures normalised to Q linea AB's reporting currency: Swedish Krona SEK

Institutional shareholders

10.26%Per cent of shares held by top holders
HolderShares% Held
Fj�rde AP-fondenas of 31 Dec 20239.40m8.02%
Aktie-Ansvar ABas of 31 Dec 20231.22m1.04%
Handelsbanken Fonder ABas of 30 Apr 2024680.03k0.58%
SEB Investment Management ABas of 30 Apr 2024601.72k0.51%
Pareto Asset Management ASas of 31 Dec 202178.00k0.07%
Skandia Investment Management ABas of 28 Mar 202424.94k0.02%
Storebrand Asset Management ASas of 31 Jan 202421.46k0.02%
Case Kapitalf�rvaltning ABas of 30 Nov 20223.58k0.00%
SSgA Funds Management, Inc.as of 09 May 2024376.000.00%
Danske Bank A/S (Investment Management)as of 30 Apr 2024330.000.00%
More ▼
Data from 31 Dec 2022 - 30 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.